Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases

IMPORTANCE:. Vasopressin is used in one-third of patients with septic shock to augment hemodynamics and reduce overall catecholamine exposure. However, the optimal clinical context in which to initiate vasopressin is unknown. OBJECTIVES:. To determine the association between norepinephrine-equivalen...

Full description

Saved in:
Bibliographic Details
Main Authors: Gretchen L. Sacha, PharmD, Abhijit Duggal, MD, MPH, MSc, Anita J. Reddy, MD, MBA, Lu Wang, MS, Seth R. Bauer, PharmD
Format: Article
Language:English
Published: Wolters Kluwer 2025-09-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000001284
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849222736595910656
author Gretchen L. Sacha, PharmD
Abhijit Duggal, MD, MPH, MSc
Anita J. Reddy, MD, MBA
Lu Wang, MS
Seth R. Bauer, PharmD
author_facet Gretchen L. Sacha, PharmD
Abhijit Duggal, MD, MPH, MSc
Anita J. Reddy, MD, MBA
Lu Wang, MS
Seth R. Bauer, PharmD
author_sort Gretchen L. Sacha, PharmD
collection DOAJ
description IMPORTANCE:. Vasopressin is used in one-third of patients with septic shock to augment hemodynamics and reduce overall catecholamine exposure. However, the optimal clinical context in which to initiate vasopressin is unknown. OBJECTIVES:. To determine the association between norepinephrine-equivalent dose, lactate concentration, and time duration from shock onset at vasopressin initiation with in-hospital mortality DESIGN, SETTING, AND PARTICIPANTS:. Retrospective, observational evaluation utilizing Medical Information Mart for Intensive Care-IV and electronic ICU Collaborative Research Database databases of adult patients with septic shock based on modified Sepsis-3 criteria receiving continuous infusion catecholamines. MAIN OUTCOMES AND MEASURES:. The associations of norepinephrine-equivalent dose, lactate concentration, and time duration from shock onset at vasopressin initiation with in-hospital mortality were evaluated with multivariable regression models. RESULTS:. In total, 1409 patients from 209 hospitals were included. At vasopressin initiation patients had a median (interquartile range) norepinephrine-equivalent dose 28.4 µg/min (16.4–42.6 µg/min), lactate concentration 3.7 mmol/L (2.5–6.2 mmol/L), and 5.6 hours (2.0–13.5 hr) had elapsed since shock onset. All three variables of interest were associated with in-hospital mortality. Three restricted cubic spline knots were identified where the relationship between norepinephrine-equivalent dose and in-hospital mortality changed substantially: 9, 28, and 72 µg/min. The odds of in-hospital mortality increased by 90% and 3.9-fold when comparing vasopressin initiation at norepinephrine-equivalent doses of 28 µg/min and 72 µg/min to 9 µg/min, respectively (adjusted odds ratio [OR], 1.90 [95% CI, 1.49–2.41] and 3.93 [95% CI, 2.74–5.64]). The odds of in-hospital mortality increased by 16% for every mmol/L in the lactate concentration at vasopressin initiation (adjusted OR, 1.16 [95% CI, 1.11–1.21]). Finally, the odds of in-hospital mortality increased by 3% for every hour in the time duration from shock onset to vasopressin initiation (adjusted OR, 1.03 [95% CI, 1.01–1.04]). CONCLUSIONS AND RELEVANCE:. Earlier adjunctive vasopressin initiation may decrease mortality in patients with septic shock.
format Article
id doaj-art-2e43e2064eb94b29b5ca99653b7ad6a2
institution Kabale University
issn 2639-8028
language English
publishDate 2025-09-01
publisher Wolters Kluwer
record_format Article
series Critical Care Explorations
spelling doaj-art-2e43e2064eb94b29b5ca99653b7ad6a22025-08-26T03:23:56ZengWolters KluwerCritical Care Explorations2639-80282025-09-0179e128410.1097/CCE.0000000000001284202509000-00001Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public DatabasesGretchen L. Sacha, PharmD0Abhijit Duggal, MD, MPH, MSc1Anita J. Reddy, MD, MBA2Lu Wang, MS3Seth R. Bauer, PharmD41 Department of Pharmacy, Cleveland Clinic, Cleveland, OH.2 Critical Care Center, Cleveland Clinic, Cleveland, OH.2 Critical Care Center, Cleveland Clinic, Cleveland, OH.3 Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH.1 Department of Pharmacy, Cleveland Clinic, Cleveland, OH.IMPORTANCE:. Vasopressin is used in one-third of patients with septic shock to augment hemodynamics and reduce overall catecholamine exposure. However, the optimal clinical context in which to initiate vasopressin is unknown. OBJECTIVES:. To determine the association between norepinephrine-equivalent dose, lactate concentration, and time duration from shock onset at vasopressin initiation with in-hospital mortality DESIGN, SETTING, AND PARTICIPANTS:. Retrospective, observational evaluation utilizing Medical Information Mart for Intensive Care-IV and electronic ICU Collaborative Research Database databases of adult patients with septic shock based on modified Sepsis-3 criteria receiving continuous infusion catecholamines. MAIN OUTCOMES AND MEASURES:. The associations of norepinephrine-equivalent dose, lactate concentration, and time duration from shock onset at vasopressin initiation with in-hospital mortality were evaluated with multivariable regression models. RESULTS:. In total, 1409 patients from 209 hospitals were included. At vasopressin initiation patients had a median (interquartile range) norepinephrine-equivalent dose 28.4 µg/min (16.4–42.6 µg/min), lactate concentration 3.7 mmol/L (2.5–6.2 mmol/L), and 5.6 hours (2.0–13.5 hr) had elapsed since shock onset. All three variables of interest were associated with in-hospital mortality. Three restricted cubic spline knots were identified where the relationship between norepinephrine-equivalent dose and in-hospital mortality changed substantially: 9, 28, and 72 µg/min. The odds of in-hospital mortality increased by 90% and 3.9-fold when comparing vasopressin initiation at norepinephrine-equivalent doses of 28 µg/min and 72 µg/min to 9 µg/min, respectively (adjusted odds ratio [OR], 1.90 [95% CI, 1.49–2.41] and 3.93 [95% CI, 2.74–5.64]). The odds of in-hospital mortality increased by 16% for every mmol/L in the lactate concentration at vasopressin initiation (adjusted OR, 1.16 [95% CI, 1.11–1.21]). Finally, the odds of in-hospital mortality increased by 3% for every hour in the time duration from shock onset to vasopressin initiation (adjusted OR, 1.03 [95% CI, 1.01–1.04]). CONCLUSIONS AND RELEVANCE:. Earlier adjunctive vasopressin initiation may decrease mortality in patients with septic shock.http://journals.lww.com/10.1097/CCE.0000000000001284
spellingShingle Gretchen L. Sacha, PharmD
Abhijit Duggal, MD, MPH, MSc
Anita J. Reddy, MD, MBA
Lu Wang, MS
Seth R. Bauer, PharmD
Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases
Critical Care Explorations
title Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases
title_full Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases
title_fullStr Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases
title_full_unstemmed Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases
title_short Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases
title_sort vasopressin initiation timing and in hospital mortality in septic shock an observational study of large public databases
url http://journals.lww.com/10.1097/CCE.0000000000001284
work_keys_str_mv AT gretchenlsachapharmd vasopressininitiationtimingandinhospitalmortalityinsepticshockanobservationalstudyoflargepublicdatabases
AT abhijitduggalmdmphmsc vasopressininitiationtimingandinhospitalmortalityinsepticshockanobservationalstudyoflargepublicdatabases
AT anitajreddymdmba vasopressininitiationtimingandinhospitalmortalityinsepticshockanobservationalstudyoflargepublicdatabases
AT luwangms vasopressininitiationtimingandinhospitalmortalityinsepticshockanobservationalstudyoflargepublicdatabases
AT sethrbauerpharmd vasopressininitiationtimingandinhospitalmortalityinsepticshockanobservationalstudyoflargepublicdatabases